Skip to main content
. Author manuscript; available in PMC: 2020 Feb 11.
Published in final edited form as: Infect Control Hosp Epidemiol. 2015 Oct 12;37(1):70–79. doi: 10.1017/ice.2015.226

TABLE 2.

Characteristics of 1,200 Enrolled Patients

Variable Value
Age, mean (SD), y 61.9 18
ICU admission 366 (30.5)
LOS, mean (SD), d 14.7 22.9
History of antibiotic allergies on admission 311 (25.9)
 Beta-lactam allergy 220 (18.3)
Received antibiotics within previous 30 d 300 (25.0)
Severely immune-compromised 150 (12.5)
 Chemotherapy 82 (6.8)
 Solid organ transplant 31 (2.6)
 AIDSa 9 (0.7)
 Bone marrow transplant 8 (0.7)
 Otherb 33 (2.7)
Charlson Comorbidity Indexc
 No comorbidities (0) 692 (57.7)
 Mild (1–5) 224 (18.7)
 Severe (>5) 284 (23.7)
McCabe-Jackson scored
 Good prognosis 664 (55.3)
 Poor long-term prognosis (>6 mo) 355 (29.6)
 Poor short-term prognosis (<6 mo) 123 (10.3)
 Death expected during hospitalization 58 (4.8)

NOTE. Data are no. (%) of patients unless otherwise indicated. ICU, intensive care unit; LOS, length of stay; PD, patient-days.

a

AIDS defined as human immunodeficiency virus with CD4 count <200 cells/mL.

b

Other conditions deemed as severe immunosuppression: 12 cases of blood cancers or other chronic or acute oncohematological conditions, 9 cases of cystic fibrosis, 2 cases of long-term steroid use for autoimmune disorders.

c

The Charlson Comorbidity Index is a weighted measure of the presence of 22 chronic conditions.27 Up to 5 International Classification of Diseases, Ninth Revision, codes per patient were recorded with chief complaints and infectious syndromes given a priority; The index was calculated during analysis using the user-written CHARLSON add-on module in Stata, version 11.

d

Assigned patients into 1 of 4 categories based on judgment of how clinical information on admission predicted likelihood of survival and recovery. We used a modified version of the severity of illness score validated in Fernandez et al.28